Analgesics in Georgia

Date: October 25, 2017
Pages: 19
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A7568A0830FEN
Leaflet:

Download PDF Leaflet

Analgesics are widely used in Georgia to treat various types of pain, most commonly headaches, and to ease symptoms at the early stages of fevers and colds. Acetaminophen, which is kept in first aid kits in many Georgian households, remained the leading product type within adult analgesics in value terms in 2017. However, the value share of acetaminophen in adult analgesics is expected to decline slightly over the forecast period due to growing concerns among consumers that this product type can...

Euromonitor International's Analgesics in Georgia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Acetaminophen Leads in Adult Analgesics But Looks Set To Lose Ground Due To Health Concerns
Ibuprofen Expected To Make Value Share Gains at the Expense of Other Product Types
Paediatric Analgesics Expected To Outperform Adult Analgesics in Value Growth Terms
Competitive Landscape
Ketonal, Voltaren and Diclac Demonstrate Low Price Elasticity Following Currency Devaluation
Efferalgan Suffers From A Lack of Advertising Support and Low Shelf Visibility
Currency Devaluation Facilitates Value Share Gains for Local Producers
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Benefits From the Changing Habits of Georgians
Regulatory Changes and Currency Devaluation Affect Review Period Cagr
International Players Face Growing Competition From Local Producers
Interest in Emerging Categories Supports Gains for Smaller Distribution Channels
Outlook for Georgian Consumer Health Remains Broadly Positive
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
  Summary 1 Research Sources
Skip to top


Analgesics: Market Research Report US$ 4,500.00 Oct, 2010 · 767 pages
Adult Mouth Care in Georgia US$ 990.00 Jul, 2013 · 18 pages
Calming and Sleeping in Georgia US$ 990.00 Jul, 2013 · 24 pages
Digestive Remedies in Georgia US$ 990.00 Oct, 2017 · 18 pages

Ask Your Question

Analgesics in Georgia
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: